What amount sold does RLL, LLC report in Form D filings?

The latest linked filings report $12.7M sold across 7 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was RLL, LLC's most recent SEC filing?

RLL, LLC's most recent Form D filing was on 2026-04-06.

How many investors does RLL, LLC have?

The most recent Form D filing lists 11 investor(s).

What type of securities does RLL, LLC offer?

RLL, LLC's SEC Form D filings indicate debt offerings.

RLL, LLC

CIK: 0001755433·Biotechnology·LUTHERVILLE, MD·Limited Liability Company

Reported Sold

$12,721,150

Total Filings

Identified Offerings

Last Filed

Apr 6, 2026

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Apr 6, 2026Form D — New notice

Reported sold: $1,984,621 · Target: Indefinite

Rule 506(b)·11 investors

Jun 24, 2025Form D — New notice

Reported sold: $0 · Target: Indefinite

Rule 506(b)·0 investors

Dec 2, 2024Form D — New notice

Reported sold: $0 · Target: Indefinite

Rule 506(b)·0 investors

Jul 27, 2021Form D — New notice

Reported sold: $8,015,002 · Target: Indefinite

Rule 506(b)·17 investors

Feb 26, 2020Form D — New notice

Reported sold: $1,537,316 · Target: $2,632,136

Rule 506(b)·2 investors

Apr 5, 2019Form D — New notice

Reported sold: $500,000 · Target: $1,000,000

Rule 506(b)·1 investor

Oct 9, 2018Form D — New notice

Reported sold: $684,211 · Target: Indefinite

Rule 506(b)·1 investor

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 7 identified offerings

$12,721,150

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

LAUREN SCHNAPER

Related Person

Appears on 6 filings

LINDA MALKAS

Related Person

Appears on 6 filings

ROBERT HICKEY

Related Person

Appears on 6 filings

JONATHAN THOMAS

Related Person

Appears on 3 filings

MICHAEL BRINKENHOFF

Related Person

Appears on 3 filings

Filing History

Date	Type	Offering target	Reported sold	Investors
Apr 6, 2026	New	Indefinite	$1,984,621	11
Jun 24, 2025	New	Indefinite	$0	0
Dec 2, 2024	New	Indefinite	$0	0
Jul 27, 2021	New	Indefinite	$8,015,002	17
Feb 26, 2020	New	$2,632,136	$1,537,316	2
Apr 5, 2019	New	$1,000,000	$500,000	1
Oct 9, 2018	New	Indefinite	$684,211	1

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Accufy Diagnostics, Inc.

Biotechnology

Offering target: $2,000,000

Filed Oct 28, 2026